Cladribine repurposed in multiple sclerosis: Making a fortune out of a generic drug

Hans J.C. Buiter, Luc Derijks, Chris J.J. Mulder

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Pages (from-to)246-247
Number of pages2
JournalEuropean Journal of Hospital Pharmacy
Volume26
Issue number5
DOIs
Publication statusPublished - 1 Sep 2019

Cite this

@article{bd7247968d9b4c7d8575e63e06f1d212,
title = "Cladribine repurposed in multiple sclerosis: Making a fortune out of a generic drug",
keywords = "cladribine, cost, DMT, drug, immune suppression, multiple sclerosis, off-label, Purine nucleoside analogues, re-discovery, subcutaneous",
author = "Buiter, {Hans J.C.} and Luc Derijks and Mulder, {Chris J.J.}",
year = "2019",
month = "9",
day = "1",
doi = "10.1136/ejhpharm-2019-002026",
language = "English",
volume = "26",
pages = "246--247",
journal = "European Journal of Hospital Pharmacy",
issn = "2047-9956",
number = "5",

}

Cladribine repurposed in multiple sclerosis : Making a fortune out of a generic drug. / Buiter, Hans J.C.; Derijks, Luc; Mulder, Chris J.J.

In: European Journal of Hospital Pharmacy, Vol. 26, No. 5, 01.09.2019, p. 246-247.

Research output: Contribution to journalEditorialAcademicpeer-review

TY - JOUR

T1 - Cladribine repurposed in multiple sclerosis

T2 - Making a fortune out of a generic drug

AU - Buiter, Hans J.C.

AU - Derijks, Luc

AU - Mulder, Chris J.J.

PY - 2019/9/1

Y1 - 2019/9/1

KW - cladribine

KW - cost

KW - DMT

KW - drug

KW - immune suppression

KW - multiple sclerosis

KW - off-label

KW - Purine nucleoside analogues

KW - re-discovery

KW - subcutaneous

UR - http://www.scopus.com/inward/record.url?scp=85071660177&partnerID=8YFLogxK

U2 - 10.1136/ejhpharm-2019-002026

DO - 10.1136/ejhpharm-2019-002026

M3 - Editorial

VL - 26

SP - 246

EP - 247

JO - European Journal of Hospital Pharmacy

JF - European Journal of Hospital Pharmacy

SN - 2047-9956

IS - 5

ER -